A look at peptides
When failures in public health, science, and politics all converge

Pulling out all the stops for a COVID-19 vaccine

Inovio-firsts-immuno-oncology

This HND piece puts the spotlight on an interesting approach to developing a COVID-19 vaccine: DNA medicine. The idea here is that DNA plasmids are introduced via a special device into the cell. There they trigger T cells to do their thing against the invading COVID virus. The company behind this unique approach is Inovio Pharmaceuticals.

Inovio has had some real success with MERS, caused by a related coronavirus, and initial studies look good for COVID. At present, Inovio is having some issues with one of its sub-contractors, and that is the subject of litigation, which hopefully should be resolved soon.

Read the complete article.

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)